Literature DB >> 9367163

Human salivary histatin-5 exerts potent fungicidal activity against Cryptococcus neoformans.

H Tsai1, L A Bobek.   

Abstract

Human salivary histatins (Hsns) have been known to be potent antifungal agents against Candida albicans for more than a decade. Here, we report that Hsns are also effective in killing another medically important opportunistic fungal pathogen, Cryptococcus neoformans, which has become a new threat among the immunocompromised patients, especially AIDS patients. In fact, the cidal activity of Hsn-5 against C. neoformans is as high as that against C. albicans.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9367163     DOI: 10.1016/s0304-4165(97)00076-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species.

Authors:  E J Helmerhorst; R F Troxler; F G Oppenheim
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

2.  In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1.

Authors:  H Situ; L A Bobek
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

3.  Influence of histatin 5 on Candida albicans mitochondrial protein expression assessed by quantitative mass spectrometry.

Authors:  Tomoko Komatsu; Erdjan Salih; Eva J Helmerhorst; Gwynneth D Offner; Frank G Oppenheim
Journal:  J Proteome Res       Date:  2010-12-06       Impact factor: 4.466

4.  Salivary protein changes in response to acute stress in medical residents performing advanced clinical simulations: a pilot proteomics study.

Authors:  Rachel K Marvin; Muncharie B Saepoo; Simiao Ye; Donald B White; Rong Liu; Kenneth Hensley; Paul Rega; Viviane Kazan; David R Giovannucci; Dragan Isailovic
Journal:  Biomarkers       Date:  2017-01-25       Impact factor: 2.658

5.  Peptide-based Antifungal Therapies against Emerging Infections.

Authors:  A Matejuk; Q Leng; M D Begum; M C Woodle; P Scaria; S-T Chou; A J Mixson
Journal:  Drugs Future       Date:  2010-03       Impact factor: 0.148

6.  Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides.

Authors:  E J Helmerhorst; I M Reijnders; W van't Hof; I Simoons-Smit; E C Veerman; A V Amerongen
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

7.  Histatin 5 initiates osmotic stress response in Candida albicans via activation of the Hog1 mitogen-activated protein kinase pathway.

Authors:  Slavena Vylkova; Woong Sik Jang; Wansheng Li; Namrata Nayyar; Mira Edgerton
Journal:  Eukaryot Cell       Date:  2007-08-22

8.  Human salivary histatin 5 fungicidal action does not induce programmed cell death pathways in Candida albicans.

Authors:  David Wunder; Jin Dong; Didi Baev; Mira Edgerton
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

9.  Histatin 5-spermidine conjugates have enhanced fungicidal activity and efficacy as a topical therapeutic for oral candidiasis.

Authors:  Swetha Tati; Rui Li; Sumant Puri; Rohitashw Kumar; Peter Davidow; Mira Edgerton
Journal:  Antimicrob Agents Chemother       Date:  2013-11-18       Impact factor: 5.191

10.  Histatin 5 resistance of Candida glabrata can be reversed by insertion of Candida albicans polyamine transporter-encoding genes DUR3 and DUR31.

Authors:  Swetha Tati; Woong Sik Jang; Rui Li; Rohitashw Kumar; Sumant Puri; Mira Edgerton
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.